Alexion Pharmaceuticals Inc ALXN:NASDAQ

Last Price$113.27NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/17/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$113.05 (1)
Ask (Size)$114.63 (1)
Day Low / HighN/A - N/A
Volume1.9 M
  • Latest Stories
  • Commentary and Analysis
Alexion Pharmaceuticals Planning Phase 3 Study of ALS Drug Ultomiris
9:28AM ET 1/14/2020 MT Newswires

Alexion Pharmaceuticals (ALXN) said pre-market Tuesday that it plans to conduct a phase 3 trial of Ultomiris for the treatment of amyotrophic lateral...

OPTIONS: Option Implied Volatility for Healthcare
5:15AM ET 12/31/2019 MT Newswires

Option implied volatility for Healthcare Alexion Pharmaceuticals (ALXN) 30-day option implied volatility is at 35; compared with its 52-week range of 29 to...

Achillion Shareholders Back $930 Million Acquisition by Alexion
10:37AM ET 12/19/2019 MT Newswires

Achillion Pharmaceuticals (ACHN) said Thursday that about 99% of its shareholders voted in support of the company's $930 million acquisition by Alexion...

Analyst Actions: Morgan Stanley Downgrades Alexion Pharmaceuticals to Equal-Weight From Overweight
7:13AM ET 12/17/2019 MT Newswires

Alexion Pharmaceuticals' (ALXN) average rating among analysts is a buy, with an average price target of $157. Price: 111.37, Change: +0.95, Percent Change:...

Alexion Acquires Two Gene-Therapy Programs in Collaboration With Dicerna
11:05AM ET 12/16/2019 MT Newswires

Dicerna Pharmaceuticals (DRNA) said Monday that Alexion (ALXN) has exercised its option to acquire exclusive rights to two additional targets under the...

Elliott Insists on 'Proactive' Sale of Alexion
12:19PM ET 12/09/2019 MT Newswires

Hedge fund manager Elliott Advisors maintained its position that a "proactive" sale would be the best approach to maximize the value of Alexion (ALXN)...

Alexion Pharmaceuticals Rejects Elliott's Suggestion to Seek Sale
10:31AM ET 12/06/2019 MT Newswires

Alexion Pharmaceuticals (ALXN) said Friday that its board decided that pursuing a proactive sale process as suggested by Elliott Advisors (UK) Ltd., would...

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Alexion Pharmaceuticals
3:10PM ET 12/05/2019 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Insider Trends: Insider at Alexion Pharmaceuticals Sells Stock for Taxes Interrupting 90-Day Buy Trend
6:54PM ET 12/04/2019 MT Newswires

Daniel Bazarko, SVP, Controller, CAO, executed a sale of 1,185 shares of Alexion Pharmaceuticals (ALXN) on Dec 02, 2019, for approximately $135,149 to...

Insider Trends: Insider at Alexion Pharmaceuticals Sells Shares for Tax Slowing 90-Day Buy Trend
6:38PM ET 12/04/2019 MT Newswires

On Dec 02, 2019, Dr Aradhana Sarin, EVP & CFO, completed a sale of 5,441 Alexion Pharmaceuticals (ALXN) shares for approximately $620,546 to meet tax...